NCT01034358 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Status COMPLETED Phase PHASE4
NCT01034111 A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178) Status COMPLETED Phase PHASE3
NCT01033760 Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM) Status COMPLETED Phase PHASE3
NCT01033318 A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED) Status COMPLETED Phase PHASE1
NCT01028391 30-Week Extension to an Initial Combination Study (24 Weeks in Duration) of Sitagliptin With Pioglitazone (0431-064) Status COMPLETED Phase PHASE3
NCT01027806 Effect of Montelukast Therapy in Obstructive Sleep Apnea(OSA) Children Status TERMINATED Phase PHASE4
NCT01027676 Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC) Status UNKNOWN Phase PHASE1/PHASE2
NCT01027182 Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01026831 Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED) Status COMPLETED Phase PHASE3
NCT01025843 Safety and Tolerability of MK-5478 in Participants With Hypertension (5478-001) Status COMPLETED Phase PHASE1
NCT01025765 The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin Status UNKNOWN Phase PHASE4
NCT01023035 Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2) Status COMPLETED Phase PHASE3
NCT01022476 Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients Status COMPLETED Phase PHASE1/PHASE2
NCT01021852 Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011) Status COMPLETED Phase PHASE2